449 related articles for article (PubMed ID: 20219981)
1. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.
Natalicchio A; Labarbuta R; Tortosa F; Biondi G; Marrano N; Peschechera A; Carchia E; Orlando MR; Leonardini A; Cignarelli A; Marchetti P; Perrini S; Laviola L; Giorgino F
Diabetologia; 2013 Nov; 56(11):2456-66. PubMed ID: 23995397
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway.
Ferdaoussi M; Abdelli S; Yang JY; Cornu M; Niederhauser G; Favre D; Widmann C; Regazzi R; Thorens B; Waeber G; Abderrahmani A
Diabetes; 2008 May; 57(5):1205-15. PubMed ID: 18252896
[TBL] [Abstract][Full Text] [Related]
4. Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells.
Jiang G; Dallas-Yang Q; Liu F; Moller DE; Zhang BB
J Biol Chem; 2003 Jan; 278(1):180-6. PubMed ID: 12409308
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
7. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
[TBL] [Abstract][Full Text] [Related]
8. Effect of PANDER in βTC6-cell lipoapoptosis and the protective role of exendin-4.
Xiang JN; Chen DL; Yang LY
Biochem Biophys Res Commun; 2012 May; 421(4):701-6. PubMed ID: 22542939
[TBL] [Abstract][Full Text] [Related]
9. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
Gupta P; Dixit D; Sen E
Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
[TBL] [Abstract][Full Text] [Related]
10. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
Bhattacharya S; Ray RM; Johnson LR
Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
12. An antitumor peptide from Musca domestica pupae (MATP) induces apoptosis in HepG2 cells through a JNK-mediated and Akt-mediated NF-κB pathway.
Zhang R; Cao X; Wang C; Hou L; Nie J; Zhou M; Feng Y
Anticancer Drugs; 2012 Sep; 23(8):827-35. PubMed ID: 22824823
[TBL] [Abstract][Full Text] [Related]
13. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line.
Hong SW; Lee J; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Mol Cell Endocrinol; 2012 Oct; 362(1-2):242-52. PubMed ID: 22820130
[TBL] [Abstract][Full Text] [Related]
14. Arg972 insulin receptor substrate-1 enhances tumor necrosis factor-α-induced apoptosis in osteoblasts.
You Y; Liu S; Peng L; Long M; Deng H; Zhao H
Mol Med Rep; 2015 Jul; 12(1):255-60. PubMed ID: 25760103
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
16. Impact of divergent effects of astaxanthin on insulin signaling in L6 cells.
Ishiki M; Nishida Y; Ishibashi H; Wada T; Fujisaka S; Takikawa A; Urakaze M; Sasaoka T; Usui I; Tobe K
Endocrinology; 2013 Aug; 154(8):2600-12. PubMed ID: 23715867
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
18. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation.
Kawasaki Y; Harashima S; Sasaki M; Mukai E; Nakamura Y; Harada N; Toyoda K; Hamasaki A; Yamane S; Yamada C; Yamada Y; Seino Y; Inagaki N
Horm Metab Res; 2010 May; 42(5):311-7. PubMed ID: 20213584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
